Skip to main content
. 2022 Dec 13;20(12):e07666. doi: 10.2903/j.efsa.2022.7666

Table 73.

Reported confirmed human cases of congenital toxoplasmosis and notification rates per 100,000 live births in EU MSs and non‐MS countries, by country and year, 2016–2020

Country 2020 2019 2018 2017 2016
National coverage (a) Data format (a) Confirmed cases and rates Confirmed cases and rates Confirmed cases and rates Confirmed cases and rates Confirmed cases and rates
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria
Belgium
Bulgaria Y A 0 0 0 0 0 0 2 3.1 0 0
Croatia Y C 0 0 0 0 1 2.7 0 0 0 0
Cyprus Y C 0 0 0 0 0 0 0 0 0 0
Czechia Y C 0 0 1 0.9 0 0 2 1.8 0 0
Denmark
Estonia Y C 0 0 0 0 1 7.2 0 0 0 0
Finland Y C 0 0 0 0 0 0 0 0 1 1.8
France Y C 110 15.5 134 18.8 151 20.8 153 20.7 195 25.9
Germany Y C 14 1.8 17 2.2 18 2.3 8 1.0 10 1.3
Greece 0 0 0 0 0 0
Hungary Y C 0 0 1 1.1 0 0 0 0 0 0
Ireland Y C 0 0 0 0 0 0 0 0 0 0
Italy
Latvia Y C 0 0 1 5.2 0 0 0 0 0 0
Lithuania Y C 0 0 0 0 0 0 0 0 0 0
Luxembourg Y C 0 0 0 0 0 0 0 0 0 0
Malta Y C 0 0 0 0 0 0 0 0 0 0
Netherlands
Poland Y C 9 2.5 14 3.7 25 6.3 18 4.8 20 5.5
Portugal
Romania Y C 0 0 0 0 1 0.48 0 0 0 0
Slovakia Y C 0 0 0 0 0 0 0 0 2 3.6
Slovenia Y C 0 0 1 5.1 2 9.9 2 9.8 1 4.8
Spain (b) , (c) N C 0 0 2 3 5
Sweden
EU Total 27 133 5.1 169 6.2 201 7.1 188 6.6 234 8.7
United Kingdom 7 1.0 7 0.9 7 0.91 8 1.0
EU Total (d) 133 5.1 176 5.1 208 5.8 195 5.4 242 6.9
Iceland Y C 0 0 0 0 0 0 0 0 0 0
Norway
Liechtenstein
Switzerland

–: Data not reported.

(a)

: Y: yes; N: no; A: aggregated data; C: case‐based data.

(b)

: Notification rate was not calculated since information on estimated coverage was not available.

(c)

: Data not complete for 2020–2021, rate not estimated.

(d)

: Cases reported by the United Kingdom for the period 2016–2019 were also considered for this estimate (EU‐28). When the United Kingdom data were collected for the period 2017–2019, the United Kingdom was an EU MS, but it became a third country on 1 February 2020.